0001235802-22-000001.txt : 20220103
0001235802-22-000001.hdr.sgml : 20220103
20220103160949
ACCESSION NUMBER: 0001235802-22-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220103
DATE AS OF CHANGE: 20220103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Giuffre Randall Michael
CENTRAL INDEX KEY: 0001759822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36291
FILM NUMBER: 22502155
MAIL ADDRESS:
STREET 1: 2 CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc.
CENTRAL INDEX KEY: 0001401040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
BUSINESS PHONE: (763) 496-5454
MAIL ADDRESS:
STREET 1: TWO CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
FORMER COMPANY:
FORMER CONFORMED NAME: DiaMedica Inc.
DATE OF NAME CHANGE: 20070525
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-01-03
0
0001401040
DiaMedica Therapeutics Inc.
DMAC
0001759822
Giuffre Randall Michael
TWO CARLSON PARKWAY
SUITE 260
MINNEAPOLIS
MN
55447
1
0
0
0
Voting Common Shares, no par value per share
2022-01-03
4
A
0
15026
3.58
A
110225
D
Voting Common Shares, no par value per share
25573
I
See footnote
Voting Common Shares, no par value per share
21070
I
By Spouse
Voting Common Shares, no par value per share
54186
I
By Children
These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $53,750.
Amount reflects the cancellation of 422 shares underlying deferred share units granted in lieu of Board committee retainers due to a change in Board committee memberships.
Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 14,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually.
These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.
/s/ Amy Culbert, attorney-in-fact
2022-01-03